
BioNano Genomics BNGO
$ 1.25
0.81%
Annual report 2025
added 03-23-2026
BioNano Genomics DIO Ratio 2011-2026 | BNGO
Annual DIO Ratio BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 251 | 245 | 394 | 352 | 203 | 211 | 186 | 44.8 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 394 | 44.8 | 236 |
Quarterly DIO Ratio BioNano Genomics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 214 | 304 | 320 | - | 124 | 413 | 394 | - | 458 | 471 | 537 | - | 211 | 143 | 270 | - | 181 | 150 | 136 | - | 207 | 502 | 360 | 186 | 132 | 202 | 180 | 32.6 | 31.8 | 53.8 | 150 | 103 | 45.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 537 | 31.8 | 233 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 17.65 | 3.67 % | $ 176 M | ||
|
Agilent Technologies
A
|
97.1 | $ 119.12 | 1.34 % | $ 36.2 B | ||
|
Myriad Genetics
MYGN
|
42.8 | $ 4.1 | -18.59 % | $ 380 M | ||
|
NeoGenomics
NEO
|
24.4 | $ 8.7 | -1.81 % | $ 1.11 B | ||
|
Natera
NTRA
|
25.8 | $ 215.43 | 4.19 % | $ 21.2 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.15 | 2.65 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Personalis
PSNL
|
12.1 | $ 6.04 | 8.54 % | $ 358 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.93 | 0.01 % | $ 2.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 20.85 | 0.7 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
86.5 | $ 475.86 | 1.96 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 0.61 | 1.13 % | $ 61.9 M | ||
|
Co-Diagnostics
CODX
|
1.69 K | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 24.82 | 0.89 % | $ 689 M | ||
|
Twist Bioscience Corporation
TWST
|
51.5 | $ 60.05 | 5.91 % | $ 3.59 B | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 186.57 | 0.64 % | $ 9.25 B | ||
|
Waters Corporation
WAT
|
528 | $ 351.47 | 2.54 % | $ 20.9 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 15.15 | 1.68 % | $ 458 M | ||
|
Guardant Health
GH
|
82.1 | $ 91.39 | 2.09 % | $ 11.5 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 124.91 | 2.96 % | $ 10.3 B | ||
|
Illumina
ILMN
|
137 | $ 141.73 | 1.91 % | $ 22.5 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.11 | 2.2 % | $ 213 M | ||
|
Interpace Biosciences
IDXG
|
29.1 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
147 | $ 2.14 | -2.06 % | $ 4.92 M | ||
|
Lantheus Holdings
LNTH
|
40.4 | $ 87.0 | 1.37 % | $ 5.87 B | ||
|
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 259.67 | 0.98 % | $ 21.6 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
147 | $ 9.28 | 0.11 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 191.61 | 0.4 % | $ 21.3 B |